Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Strong Long	4/1/2016 6:59:03 PM
	Read Replies (1) of 2026

I keep replaying Pascoes recent webcast addressing the Fis results and the companies plans moving forward. It is hard for me to believe that Pascoe thinks that Apricus can be a profitable company by next year...by 2017! I'm trying to see or hear the logic in his words...even if it's cryptic. To date, it is fair to say that Apricus has missed guidance often, and now it seems that some of the companies decisions have been poor (Fis). People are dumping this stock like crazy. That can be expected with the Fis results and losing those that were here because Denner was here (for Fispemifine). Here are some things that Pascoe says going forward to obtain profitability by next year: • Gain FDA approval of Vitaros in the US in 2017...hope so. • raise revenue through royalty and milestone payments...he must think that some milestone payments will kick in before the end of 2017? • Grow sales in the existing markets in Europe. • Ensure that Vitaros is available in countries that have already approved and marketed Vitaros...I think this is a Germany/Sandoz reference (my view) • Launch additional markets in Europe where Vitaros is already approved. • Seek approval in other countries in Europe and South America...I assume he would expect upfront payments? • Reduce costs by streamlining • Reduced capital needs I look forward to seeing his revised expectation for how long he thinks our cash on hand can last. It is my hope that he takes serious the job of streamlining. He really might want to consider compensation at the top as a streamlining measure. He does express that the plans moving forward are meant to create meaningful value for long term shareholders. I can only assume that he ultimately thinks that the long term pps will be higher than the pps held by our long term holders. We took it on the chin this week. If my tone sounds disappointed...I certainly am, and I'm sure all of you are as well. Let's hope for some positives moving forward.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next